Epidemiology, radiology, and genetics of nicotine dependence in COPD
Open Access
- 1 December 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Respiratory Research
- Vol. 12 (1), 9
- https://doi.org/10.1186/1465-9921-12-9
Abstract
Background Cigarette smoking is the principal environmental risk factor for developing COPD, and nicotine dependence strongly influences smoking behavior. This study was performed to elucidate the relationship between nicotine dependence, genetic susceptibility to nicotine dependence, and volumetric CT findings in smokers. Methods Current smokers with COPD (GOLD stage ≥ 2) or normal spirometry were analyzed from the COPDGene Study, a prospective observational study. Nicotine dependence was determined by the Fagerstrom test for nicotine dependence (FTND). Volumetric CT acquisitions measuring the percent of emphysema on inspiratory CT (% of lung <-950 HU) and gas trapping on expiratory CT (% of lung <-856 HU) were obtained. Genotypes for two SNPs in the CHRNA3/5 region (rs8034191, rs1051730) previously associated with nicotine dependence and COPD were analyzed for association to COPD and nicotine dependence phenotypes. Results Among 842 currently smoking subjects (335 COPD cases and 507 controls), 329 subjects (39.1%) showed high nicotine dependence. Subjects with high nicotine dependence had greater cumulative and current amounts of smoking. However, emphysema severity was negatively correlated with the FTND score in controls (ρ = -0.19, p < .0001) as well as in COPD cases (ρ = -0.18, p = 0.0008). Lower FTND score, male gender, lower body mass index, and lower FEV1 were independent risk factors for emphysema severity in COPD cases. Both CHRNA3/5 SNPs were associated with FTND in current smokers. An association of genetic variants in CHRNA3/5 with severity of emphysema was only found in former smokers, but not in current smokers. Conclusions Nicotine dependence was a negative predictor for emphysema on CT in COPD and control smokers. Increased inflammation in more highly addicted current smokers could influence the CT lung density distribution, which may influence genetic association studies of emphysema phenotypes. Trial registration ClinicalTrials (NCT): NCT00608764Keywords
This publication has 45 references indexed in Scilit:
- Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trialEuropean Respiratory Journal, 2009
- Evolution of emphysema in relation to smokingEuropean Radiology, 2009
- The Effects of Smoking Cessation on the Risk of Chronic Obstructive Pulmonary Disease ExacerbationsJournal of General Internal Medicine, 2009
- Pharmacology of Nicotine: Addiction, Smoking-Induced Disease, and TherapeuticsAnnual Review of Pharmacology and Toxicology, 2009
- Natural History of EmphysemaProceedings of the American Thoracic Society, 2008
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Global burden of COPD: risk factors, prevalence, and future trendsThe Lancet, 2007
- Risk factors of readmission to hospital for a COPD exacerbation: a prospective studyThorax, 2003
- Cough and Phlegm Are Important Predictors of Health Status in Smokers Without COPDSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2002
- The natural history of chronic airflow obstruction.BMJ, 1977